150 related articles for article (PubMed ID: 6434946)
1. Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome.
Comite F; Shawker TH; Pescovitz OH; Loriaux DL; Cutler GB
N Engl J Med; 1984 Oct; 311(16):1032-6. PubMed ID: 6434946
[No Abstract] [Full Text] [Related]
2. Ovarian function in girls with McCune-Albright syndrome.
Foster CM; Feuillan P; Padmanabhan V; Pescovitz OH; Beitins IZ; Comite F; Shawker TH; Loriaux DL; Cutler GB
Pediatr Res; 1986 Sep; 20(9):859-63. PubMed ID: 3092175
[TBL] [Abstract][Full Text] [Related]
3. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
[TBL] [Abstract][Full Text] [Related]
4. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
[TBL] [Abstract][Full Text] [Related]
5. Autonomous ovarian hyperfunction followed by gonadotrophin-dependent puberty in McCune-Albright syndrome.
Kaufman FR; Costin G; Reid BS
Clin Endocrinol (Oxf); 1986 Mar; 24(3):239-42. PubMed ID: 3085997
[TBL] [Abstract][Full Text] [Related]
6. McCune-Albright syndrome: evidence for autonomous multiendocrine hyperfunction.
D'Armiento M; Reda G; Camagna A; Tardella L
J Pediatr; 1983 Apr; 102(4):584-6. PubMed ID: 6403689
[No Abstract] [Full Text] [Related]
7. Testolactone treatment of precocious puberty in McCune-Albright syndrome.
Foster CM; Pescovitz OH; Comite F; Feuillan P; Shawker T; Loriaux DL; Cutler GB
Acta Endocrinol (Copenh); 1985 Jun; 109(2):254-7. PubMed ID: 3925675
[TBL] [Abstract][Full Text] [Related]
8. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome.
Foster CM; Ross JL; Shawker T; Pescovitz OH; Loriaux DL; Cutler GB; Comite F
J Clin Endocrinol Metab; 1984 Jun; 58(6):1161-5. PubMed ID: 6427261
[TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.
Feuillan PP; Jones J; Oerter KE; Manasco PK; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1370-3. PubMed ID: 1955519
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
[TBL] [Abstract][Full Text] [Related]
11. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
Léger J; Reynaud R; Czernichow P
J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
[TBL] [Abstract][Full Text] [Related]
12. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.
Comite F; Cutler GB; Rivier J; Vale WW; Loriaux DL; Crowley WF
N Engl J Med; 1981 Dec; 305(26):1546-50. PubMed ID: 6458765
[TBL] [Abstract][Full Text] [Related]
13. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.
Eugster EA; Rubin SD; Reiter EO; Plourde P; Jou HC; Pescovitz OH;
J Pediatr; 2003 Jul; 143(1):60-6. PubMed ID: 12915825
[TBL] [Abstract][Full Text] [Related]
16. Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
Roth C; Freiberg C; Zappel H; Albers N
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():945-8. PubMed ID: 12199354
[TBL] [Abstract][Full Text] [Related]
17. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
Feuillan PP; Jones J; Cutler GB
J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
[TBL] [Abstract][Full Text] [Related]
18. Ovarian function in three female patients with McCune-Albright syndrome with persistent autonomous ovarian activity.
Maesaka H; Abe Y; Tachibana K; Adachi M; Asakura Y
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():903-11. PubMed ID: 12199349
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea.
Carani C; Pacchioni C; Baldini A; Zini D
J Endocrinol Invest; 1988 Jun; 11(6):419-23. PubMed ID: 2974851
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of ovarian function in an adult woman with McCune--Albright syndrome.
Laven JS; Lumbroso S; Sultan C; Fauser BC
J Clin Endocrinol Metab; 2001 Jun; 86(6):2625-30. PubMed ID: 11397863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
